JPS588007A - Cosmetic for making skin soft - Google Patents
Cosmetic for making skin softInfo
- Publication number
- JPS588007A JPS588007A JP10424681A JP10424681A JPS588007A JP S588007 A JPS588007 A JP S588007A JP 10424681 A JP10424681 A JP 10424681A JP 10424681 A JP10424681 A JP 10424681A JP S588007 A JPS588007 A JP S588007A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- basic amino
- cosmetic
- skin
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- 150000001413 amino acids Chemical class 0.000 claims abstract description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 8
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 7
- 239000004472 Lysine Substances 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 6
- 239000004310 lactic acid Substances 0.000 abstract description 4
- 235000014655 lactic acid Nutrition 0.000 abstract description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000011975 tartaric acid Substances 0.000 abstract description 2
- 235000002906 tartaric acid Nutrition 0.000 abstract description 2
- 150000001261 hydroxy acids Chemical class 0.000 abstract 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- NYHNVHGFPZAZGA-UHFFFAOYSA-N 2-hydroxyhexanoic acid Chemical compound CCCCC(O)C(O)=O NYHNVHGFPZAZGA-UHFFFAOYSA-N 0.000 abstract 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 abstract 1
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical compound CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 abstract 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 210000000434 stratum corneum Anatomy 0.000 description 22
- 239000002253 acid Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- VLHZUYUOEGBBJB-UHFFFAOYSA-N hydroxy stearic acid Natural products OCCCCCCCCCCCCCCCCCC(O)=O VLHZUYUOEGBBJB-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- -1 ordigane Chemical compound 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 239000004169 Hydrogenated Poly-1-Decene Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- FSBIGDSBMBYOPN-VKHMYHEASA-N L-canavanine Chemical compound OC(=O)[C@@H](N)CCONC(N)=N FSBIGDSBMBYOPN-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- FSBIGDSBMBYOPN-UHFFFAOYSA-N O-guanidino-DL-homoserine Natural products OC(=O)C(N)CCON=C(N)N FSBIGDSBMBYOPN-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019383 crystalline wax Nutrition 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical compound [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、分子中に水酸基とカルボキシル基をもつオキ
シ酸と、塩基性アミノ酸を含む皮膚柔軟化粧料に関する
。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a skin softening cosmetic containing an oxyacid having a hydroxyl group and a carboxyl group in its molecule and a basic amino acid.
皮膚の最外層である角質層は、冬期、低温、低湿など厳
しい気象条件下で、しばしば乾燥したりざらつく。この
ようなことは、また洗剤、溶剤の過度の使用においても
みられる。この皮膚の変化は角質層中のNMF(天然保
湿因子:ナチュラルモイスチュアライジング・ファクタ
ー)とよばれる吸湿性の水溶性成分が失なわれ、角質層
中の水分が減少し角質層の柔軟性がなくなるためである
と考えられている。それゆえ、従来の皮膚を柔軟にする
ための化粧料には、角質層に水分をできるだけ多く与え
、なおかつ、それを長時間保持させることを考慮し、さ
まざまな保湿剤が配合されてきた。また、α−オキシ酸
の角層柔軟作用を利用したものも提案されている。(特
公昭55−19291号公報)しかし保湿剤の皮膚への
適用は、その効果が一過性であり、永続しない。また、
α−オキシ酸の適用は正常な皮膚生理を阻害するような
低いpH領域(PH2〜4)でしか、その効果が発現さ
れないなど欠点が多い・
この欠点を補うために、水酸化ナトリウムや水酸化カリ
ウムなどの強アルカリやトリエタノールアミンなどのア
ミン類を添加して中性pH領域で実施した例もみられる
が、これらの強アルカリは、多量に配合すると安定性が
悪いものもみられ、皮膚のpH域に合わせるのにも困難
を伴ない、一定の品質が得られ難い。また、アミン類に
ついては、文献等にみられるように、長期連用した場合
、体質によってはアレルギーの認められることが知られ
ているので、他の中和剤を用いた方が好ましい。The outermost layer of the skin, the stratum corneum, often becomes dry and rough during harsh weather conditions such as winter, low temperature, and low humidity. This can also occur with excessive use of detergents and solvents. This skin change is caused by the loss of a hygroscopic, water-soluble component called NMF (natural moisturizing factor) in the stratum corneum, resulting in a decrease in moisture in the stratum corneum and loss of flexibility of the stratum corneum. It is believed that this is for the purpose of Therefore, conventional cosmetics for softening the skin have been formulated with various moisturizing agents in order to provide as much moisture as possible to the stratum corneum and retain it for a long time. Furthermore, a method utilizing the stratum corneum softening effect of α-oxyacid has also been proposed. (Japanese Patent Publication No. 55-19291) However, when a moisturizer is applied to the skin, its effect is temporary and not permanent. Also,
The application of α-oxyacids has many drawbacks, such as the effect is only expressed in a low pH range (PH2-4) that inhibits normal skin physiology.To compensate for this drawback, sodium hydroxide and hydroxide There have been cases where strong alkalis such as potassium or amines such as triethanolamine were added to achieve a neutral pH range, but these strong alkalis tend to be unstable when added in large amounts, and may affect the pH of the skin. It is difficult to adjust the quality to the target area, and it is difficult to obtain a certain level of quality. Furthermore, as seen in the literature, it is known that long-term use of amines can cause allergies in some people, so it is preferable to use other neutralizing agents.
本発明者らは、これらの欠点を解決するため、鋭意研究
を重ねた結果特定のオキシ酸と、生体構成成分で、NM
F中の遊離アミノ酸として存在し皮膚科学的に安全性が
立証されている塩基性アミノ醗を配合することにより、
皮膚のpHである弱酸性(PH4,5〜7)で従来の化
粧料に比して皮膚科学的に極めて安全で、角層の保質性
、柔軟性に秀れ、著しく長時間柔軟効果を持続させるこ
とができる化粧料を見い出し完成するに至った。In order to solve these drawbacks, the present inventors have conducted extensive research and have discovered that NM
By incorporating basic amino acid, which exists as a free amino acid in F and is dermatologically proven to be safe,
It is weakly acidic (PH4.5-7), which is the pH of the skin, and is dermatologically extremely safe compared to conventional cosmetics.It has excellent retention and flexibility of the stratum corneum, and has an extremely long-lasting softening effect. They have discovered and completed a cosmetic that can last for a long time.
即ち、本発明は、分子中に2から摺の炭素原子を有する
オキシ酸と、塩基性アミノ酸を配合したことを特徴とす
る皮膚柔軟化粧料を提供するものである。That is, the present invention provides a skin softening cosmetic characterized by containing an oxyacid having 2 to 3 carbon atoms in the molecule and a basic amino acid.
本発明によれば、オキシ酸に塩基性アミノ酸を組合せる
ことによってオキシ酸単独よりも吸湿性が著しく向上し
角層に付与される水分量が増し、その結果、皮膚の角層
を柔軟にして、角質細胞の正常な代部を助けるという効
果を発揮することができる。According to the present invention, by combining a basic amino acid with an oxyacid, the hygroscopicity is significantly improved compared to the oxyacid alone, and the amount of moisture imparted to the stratum corneum is increased.As a result, the stratum corneum of the skin is softened and , can exhibit the effect of supporting the normal replacement of corneocytes.
次に本発明の構成について述べる。本発明に用いられる
オキシ酸は、たとえば、グリフール酸、乳酸、オキシ酪
酸、オキシ吉草酸、オキシカプロン酸・オキシウンデ酸
、オキシカプリル酸、オキシカプリン酸、オキシウンデ
カ酸、オキシラウリン酸、オキシトリデカン酸、オキシ
寸トラデカン酸、オキシペンタデカン酸、オキシバルミ
千ン酸、オキシカプリン酸、オキシステアリン酸、マン
デル酸、クエン酸、酒石酸、リンゴ酸等の分子中に2か
ら摺の炭素数を有するオキシ酸である。Next, the configuration of the present invention will be described. The oxyacids used in the present invention include, for example, glyfuric acid, lactic acid, oxybutyric acid, oxyvaleric acid, oxycaproic acid/oxyundic acid, oxycaprylic acid, oxycapric acid, oxyundecic acid, oxylauric acid, oxytridecanoic acid, These are oxyacids having 2 to 3 carbon atoms in the molecule, such as oxytradecanoic acid, oxypentadecanoic acid, oxybalmicinic acid, oxycapric acid, oxystearic acid, mandelic acid, citric acid, tartaric acid, and malic acid.
本発明で用いられる塩基性アミノ酸は、たとえハ、リジ
ン、アルギニン、ヒスチジン、オル二手ン、カナバニン
等である。The basic amino acids used in the present invention include, for example, lysine, arginine, histidine, ordigane, canavanine, and the like.
オキシ酸と塩基性アミノ酸との割合はモル比で]:α5
〜α5:1であるが、好ましくはl;α7〜α7;1の
ように等量に近い比が望ましい。化粧料中に含まれるオ
キシ酸と塩基性アミノ酸の混合物の濃度は重量で01〜
加%であるが、好ましくは1N1D%である。The ratio of oxyacid to basic amino acid is molar ratio]: α5
~α5:1, but preferably a ratio close to equivalence such as l;α7 to α7;1. The concentration of the mixture of oxyacid and basic amino acid contained in cosmetics ranges from 0.1 to 0.01 by weight.
%, preferably 1N1D%.
本発明において、オキシ酸と塩基性アミノ酸は塩として
配合してもかまわない。In the present invention, the oxyacid and the basic amino acid may be blended as a salt.
本発明の皮膚柔軟化粧料は、以上の必須成分の他に、界
面活性剤、油分、保湿剤、水等化粧料として一般に用い
られる基剤が必要に応じて配合される。In addition to the above-mentioned essential ingredients, the skin softening cosmetic composition of the present invention may optionally contain bases commonly used in cosmetic compositions, such as surfactants, oils, humectants, and water.
次に、実施例により本発明をさらに詳細に説明する。な
お、配合量は特に記載のあるものを除き重量%である。Next, the present invention will be explained in more detail with reference to Examples. In addition, the blending amounts are weight % unless otherwise specified.
実施例1
α−オキシカプリル酸 0.15M α249リジ
ン O,15M 21.99水
ets
4.1(i比較例1
α−オキシカプリル酸 α15M 24.□i7水
9
76.09製造方法
α−オキシカプリル酸拠りとリジン21.9りを水に溶
かし、全体がxooo 9になるように水を加える。Example 1 α-oxycaprylic acid 0.15M α249 Lysine O, 15M 21.99 Water
ets
4.1 (i Comparative Example 1 α-oxycaprylic acid α15M 24.□i7 Water 9
76.09 Manufacturing method Dissolve α-oxycaprylic acid and lysine 21.9 in water, and add water so that the total amount is xooo 9.
オキシカルギン酸と塩基性アミノ酸を配合した水溶液(
実施例1)とオキシカルボン酸のみを含む水溶液(比較
例1)のpH1角層に対する保湿性、・充分浸漬した後
、測定湿度中に放置して行い、定重量に達した時の、角
層100 Wui中の水分量(■)を吸湿量として表わ
した。Aqueous solution containing oxycarginic acid and basic amino acids (
Moisturizing properties of the pH 1 stratum corneum of Example 1) and an aqueous solution containing only oxycarboxylic acid (Comparative Example 1) - After sufficient immersion, the stratum corneum was left to stand in the measurement humidity, and when a constant weight was reached, the stratum corneum The amount of water (■) in 100 Wui was expressed as the amount of moisture absorbed.
又、柔軟効果の測定は、2)a X 5m811の角層
片に試験水溶液2μノを塗布し、東洋製機製の動的粘弾
性測定装置を用い弾性率を測定した。The softening effect was measured by applying 2 μm of the test aqueous solution to a 2) a x 5m811 piece of the stratum corneum, and measuring the elastic modulus using a dynamic viscoelasticity measuring device manufactured by Toyo Seiki.
柔軟効果は、ブランクとして測定した角層の弾性率(E
)に対する、試験水溶液塗布後を時間の弾性率(Ict
)の比E/Etで表わした。The flexibility effect is determined by the elastic modulus (E) of the stratum corneum measured as a blank.
), the elastic modulus (Ict
) is expressed as the ratio E/Et.
結果を表1、図1.2に示す。The results are shown in Table 1 and Figure 1.2.
表1、実施例1と比較例1のpH
pH
実施例1 6.58
比較例12−40
表1から明きらかなように、実施例1は比較例1に比へ
て・pHは、中性付近である。このことは、塩基性アミ
ノ酸添加によって皮フ生理学上安全性が高まったことを
示している。また、実施例1と比較例2の各水溶液を角
層に塗布した後の角層の吸湿量は・第1図からみても明
らかなように、塩基性アミノ酸添加によって、大きく向
上した。Table 1, pH of Example 1 and Comparative Example 1 pH Example 1 6.58 Comparative Example 12-40 As is clear from Table 1, Example 1 is compared to Comparative Example 1.The pH is neutral. It's nearby. This indicates that the addition of basic amino acids increased the physiological safety of the skin. Furthermore, the amount of moisture absorbed by the stratum corneum after each of the aqueous solutions of Example 1 and Comparative Example 2 was applied to the stratum corneum was greatly improved by the addition of the basic amino acid, as is clear from FIG.
一方・角層に対する柔軟効果も、塩基性アミノ酸の添加
により、著しく、増加することが第2図より明きらかで
ある。On the other hand, it is clear from FIG. 2 that the softening effect on the stratum corneum is also significantly increased by the addition of basic amino acids.
(以下余白)
実施例2
柔軟化粧水
クエン酸 2−8リジン
a2グリセリン
3.0プロピレングリコール
40ジプロピレングリコール
40ポリオキシエチレン(圧
モ/I/)ソルビタンモノラウリン酸エステル
15エチルアルコール
lα0蒸留水 ’13
香料 αl防腐剤
αl(製造方法)
蒸留水にクエン酸・リジン−グリセリン・プルピレング
リコール、ジプロピレングリコールヲ加え、室温にて溶
解する(水都)。エチルアルコールにポリオキシエチレ
ンソルビタンモノラウリン酸エステル香料、防腐剤を加
え、室温にて溶解する(アルコール部)。水都にアルコ
ール部を加え柔軟化粧水を得る。(Left below) Example 2 Soft lotion citric acid 2-8 lysine a2 glycerin
3.0 propylene glycol
40 dipropylene glycol
40 polyoxyethylene (pressure/I/) sorbitan monolaurate
15 ethyl alcohol
lα0 distilled water '13
Fragrance αl preservative
αl (Production method) Add citric acid, lysine-glycerin, propylene glycol, and dipropylene glycol to distilled water and dissolve at room temperature (Suito). Add polyoxyethylene sorbitan monolaurate fragrance and preservative to ethyl alcohol and dissolve at room temperature (alcohol part). Add an alcohol part to Suito to obtain a softening lotion.
得られた柔軟化粧水は、角層に対して優れた保湿効果、
柔軟効果を示した。The obtained softening lotion has an excellent moisturizing effect on the stratum corneum,
It showed a softening effect.
実施例3
W10型乳液
マイク四クリスタリンワックス 1
.0ミツロウ zOシラノ
ン 20流動パラフイン
30・0ソルビタンセスキオ
レイン酸エステル 40ポリオキシエチレ
ンソルピタンモノオレイ妻ステル(20EQ)1.0ス
テアリン酸アルミニウム 0
.2乳酸 1.7フル
ギエン 2,6蒸留水
55.4香料
α4防腐剤
0.4(製造方法)
蒸留水に乳酸、アルギニ−ンを加え加熱して70℃に保
つ(水相)。他の成分を混合し加熱溶解して70′Cに
保つ(油相)。油相を攪拌しながら、これに水相を徐々
に加えホモミキサーで均一に乳化する。乳化後攪拌しな
がら30’Cまで冷却する。Example 3 W10 type emulsion microphone 4 crystalline wax 1
.. 0 beeswax zO silanone 20 liquid paraffin
30.0 Sorbitan sesquioleate 40 Polyoxyethylene sorbitan monooleitate (20EQ) 1.0 Aluminum stearate 0
.. 2 Lactic acid 1.7 Fulgiene 2.6 Distilled water
55.4 Fragrance
α4 preservative
0.4 (Production method) Add lactic acid and arginine to distilled water, heat and maintain at 70°C (aqueous phase). Mix other ingredients and heat to dissolve and maintain at 70'C (oil phase). While stirring the oil phase, gradually add the water phase to it and uniformly emulsify with a homomixer. After emulsification, cool to 30'C while stirring.
得られた乳液は、角層に対して優れた保湿効果・柔軟効
果を示した。The obtained emulsion exhibited excellent moisturizing and softening effects on the stratum corneum.
実施例牛
Q/W型クワクリ
ームロウ lα0セチルア
ルコール 50水添う/リン
aOスクワラン
37.5グリセリルモノステアリン酸エステル
zOポリオキシモルシ(2
0モル)ソルビタンモノラウリン酸エステル
2.0プロピレングリコール 5・0オ
キシステアリン酸 47リジン
z2蒸留水
259香料 ・
α5防腐剤
α5(製造方法)
蒸留水にプロピレングリコール、オキシステアリン酸・
リジンを加え、加熱して70°Cに保つ(水相)0他の
成分を混合し、加熱溶解して70°Cに保つ(油相)。Example Beef Q/W type mulberry cream wax lα0 cetyl alcohol 50 hydrogenated/phosphorus
aO squalane
37.5 Glyceryl monostearate zO polyoxymorsi (2
0 mol) Sorbitan monolaurate
2.0 Propylene Glycol 5.0 Oxystearic Acid 47 Lysine
z2 distilled water
259 fragrance ・
α5 preservative
α5 (Production method) Distilled water, propylene glycol, oxystearic acid,
Add lysine, heat and keep at 70°C (water phase). Mix other ingredients, heat and dissolve and keep at 70°C (oil phase).
水相に油相を加え予備乳化を行ない・ホモミキサーで均
一に乳化し、乳化後冷却しながらかきまぜる。Pre-emulsify by adding the oil phase to the water phase. Uniformly emulsify with a homomixer, and after emulsification, stir while cooling.
得られた乳液は角層に対して優れた保湿効果、柔軟効果
を示した。The obtained emulsion exhibited excellent moisturizing and softening effects on the stratum corneum.
第1図は、実施例1、比較例1及び蒸留水で処理した角
層の保湿性を示すグラフ。
第2図は・実施例1及び比較例1の角層に対する柔軟効
果を示すグラフ。
特許出願人 株式会社 資 生 堂FIG. 1 is a graph showing the moisturizing properties of the stratum corneum treated with Example 1, Comparative Example 1, and distilled water. FIG. 2 is a graph showing the softening effect on the stratum corneum of Example 1 and Comparative Example 1. Patent applicant Shiseido Co., Ltd.
Claims (1)
酸と、塩基性アミノ酸を配合したことを特徴とする皮膚
柔軟化粧料。(1) A skin softening cosmetic characterized by containing an oxyacid having 2 to 3 carbon atoms in its molecule and a basic amino acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10424681A JPS588007A (en) | 1981-07-03 | 1981-07-03 | Cosmetic for making skin soft |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10424681A JPS588007A (en) | 1981-07-03 | 1981-07-03 | Cosmetic for making skin soft |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS588007A true JPS588007A (en) | 1983-01-18 |
| JPH0330566B2 JPH0330566B2 (en) | 1991-04-30 |
Family
ID=14375578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10424681A Granted JPS588007A (en) | 1981-07-03 | 1981-07-03 | Cosmetic for making skin soft |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS588007A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63166837A (en) * | 1986-12-23 | 1988-07-11 | ユージーン・ジェイ・ヴァン・スコット | Therapeutic effect increasing method and therapeutic drug composition |
| JPH05139947A (en) * | 1991-04-10 | 1993-06-08 | Ruey J Yu | Compositions containing 2-hydroxycarboxylic acids and related compounds, and methods for alleviating dermatological signs of aging |
| WO1995015147A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances |
| FR2737407A1 (en) * | 1995-07-31 | 1997-02-07 | Oreal | USE OF HYDROXYLATED CARBOXYLIC ACIDS FOR THE TREATMENT OF KERATINIC MATERIALS |
| US5612376A (en) * | 1986-12-23 | 1997-03-18 | Tristrata Technology, Inc. | Method of treating wrinkles using 3-phenyllactic acid |
| US5637615A (en) * | 1986-12-23 | 1997-06-10 | Tristrata Technology, Inc. | Method of using tropic acid for treating wrinkles |
| JPH09268120A (en) * | 1996-04-03 | 1997-10-14 | Pola Chem Ind Inc | Water-in-oil type emulsified composition |
| US5702688A (en) * | 1986-12-23 | 1997-12-30 | Tristrata Technology, Inc. | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| FR2756489A1 (en) * | 1996-12-02 | 1998-06-05 | Eynard Michele | Treatment of hyperkeratoses |
| US5834510A (en) * | 1986-12-23 | 1998-11-10 | Tristrata Technology, Inc. | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging |
| EP0744175A3 (en) * | 1995-05-23 | 1999-05-19 | Beiersdorf Aktiengesellschaft | Cosmetic or dermatological compositions containing alpha-hydroxy fatty acids |
| US5942250A (en) * | 1986-12-23 | 1999-08-24 | Tristrata Technology, Inc. | Compositions and methods for enhancing the topical effects of sunscreen agents |
| JP2000327560A (en) * | 1999-05-18 | 2000-11-28 | Noevir Co Ltd | Bathing agent composition |
| US6191167B1 (en) | 1997-12-29 | 2001-02-20 | Tristrata Technology, Inc. | Pharmaceutical compositions containing hydroxycarboxylic acid and/or ketocarboxylic acids and methods of using the same |
| CN1065527C (en) * | 1994-07-26 | 2001-05-09 | 花王株式会社 | Guanidine derivatives, process for producing granidine derivatives and cosmetics containing guanidine derivatives |
| JP2002087923A (en) * | 2000-09-11 | 2002-03-27 | Kose Corp | Cosmetic |
| JP2004244341A (en) * | 2003-02-12 | 2004-09-02 | Noevir Co Ltd | Weakly acidic external preparation for skin and weakly acidic skin cleanser |
| JP2008174525A (en) * | 2007-01-22 | 2008-07-31 | Naris Cosmetics Co Ltd | Toilet lotion |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5277011A (en) * | 1975-12-23 | 1977-06-29 | Ajinomoto Co Inc | Preparation of l-malate |
| JPS5519291A (en) * | 1978-07-24 | 1980-02-09 | Unilever Nv | Cosmetic composition |
-
1981
- 1981-07-03 JP JP10424681A patent/JPS588007A/en active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5277011A (en) * | 1975-12-23 | 1977-06-29 | Ajinomoto Co Inc | Preparation of l-malate |
| JPS5519291A (en) * | 1978-07-24 | 1980-02-09 | Unilever Nv | Cosmetic composition |
Cited By (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5674899A (en) * | 1986-12-23 | 1997-10-07 | Tristrata Technology, Inc. | Method of using lactic acid for treating wrinkles |
| US5962526A (en) * | 1986-12-23 | 1999-10-05 | Tristrata Technology, Inc. | Pharmaceutical compositions containing hydroxycarboxylic acids and/or ketocarboxylic acids and methods of using same |
| US5637615A (en) * | 1986-12-23 | 1997-06-10 | Tristrata Technology, Inc. | Method of using tropic acid for treating wrinkles |
| US5643953A (en) * | 1986-12-23 | 1997-07-01 | Tristrata Technology | Method of using 3-phenyllactic acid for treating wrinkles |
| US5643961A (en) * | 1986-12-23 | 1997-07-01 | Tristrata Technology, Inc. | Method of using malic acid for treating wrinkles |
| US5643952A (en) * | 1986-12-23 | 1997-07-01 | Tristrata Technology, Inc. | Method of using 2-phenyllactic acid for treating wrinkles |
| US5643963A (en) * | 1986-12-23 | 1997-07-01 | Tristrata Technology, Inc. | Method of using isocitric acid for treating wrinkles |
| US5643962A (en) * | 1986-12-23 | 1997-07-01 | Tristrata Technology, Inc. | Method of using glucoleptonic acid for treating wrinkles |
| US5648391A (en) * | 1986-12-23 | 1997-07-15 | Tristrata Technology, Inc. | Method of using galacturonic acid or galacturonolactone for treating wrinkles |
| US5648388A (en) * | 1986-12-23 | 1997-07-15 | Tristrata Technology, Inc. | Method of using methyllactic acid for treating wrinkles |
| US5648395A (en) * | 1986-12-23 | 1997-07-15 | Tristrata Technology, Inc. | Method of using tartaric acid for treating wrinkles |
| US5650437A (en) * | 1986-12-23 | 1997-07-22 | Tristrata Technology, Inc. | Method of using benzilic acid for treating wrinkles |
| US5650440A (en) * | 1986-12-23 | 1997-07-22 | Tristrata Technology, Inc. | Method of using citramalic acid for treating wrinkles |
| US5650436A (en) * | 1986-12-23 | 1997-07-22 | Tristrata Technology, Inc. | Method of using galactonic acid or galactonolactone for treating wrinkles |
| US5652267A (en) * | 1986-12-23 | 1997-07-29 | Tristrata Technology, Inc. | Method of using saccharic acid or saccharolactone for treating wrinkles |
| US5654340A (en) * | 1986-12-23 | 1997-08-05 | Tristrata Technology | Method of using gulonic acid or gulonolactone for treating wrinkles |
| US5654336A (en) * | 1986-12-23 | 1997-08-05 | Tristrata Technology, Inc. | Methods of using glycolic acid for reversing or retarding the effect of aging on human facial skin |
| US5656665A (en) * | 1986-12-23 | 1997-08-12 | Tristrata Technology, Inc. | Method of using quinic acid or quinolactone for treating wrinkles |
| US5656666A (en) * | 1986-12-23 | 1997-08-12 | Tristrata Technology, Inc. | Method of using ribonic acid or ribonolactone for treating wrinkles |
| US5668177A (en) * | 1986-12-23 | 1997-09-16 | Tristrata Technology, Inc. | Method of treating wrinkles using tartaric acid |
| US5670541A (en) * | 1986-12-23 | 1997-09-23 | Tristrata Technology, Inc. | Method of treating wrinkles using gulonic acid or gulonolactone |
| US5670543A (en) * | 1986-12-23 | 1997-09-23 | Tristrata Technology, Inc. | Method of using pantoic acid or pantolactone for treating wrinkles |
| US5670542A (en) * | 1986-12-23 | 1997-09-23 | Tristrata Technology, Inc. | Method of using glucuronic acid or glucronolactone for treating wrinkles |
| US5674903A (en) * | 1986-12-23 | 1997-10-07 | Tristrata Technology, Inc. | Method of using citric acid for treating wrinkles |
| US5612376A (en) * | 1986-12-23 | 1997-03-18 | Tristrata Technology, Inc. | Method of treating wrinkles using 3-phenyllactic acid |
| JPS63166837A (en) * | 1986-12-23 | 1988-07-11 | ユージーン・ジェイ・ヴァン・スコット | Therapeutic effect increasing method and therapeutic drug composition |
| US5677340A (en) * | 1986-12-23 | 1997-10-14 | Tristrata Technology, Inc. | Method of using gluconic acid or gluconolactone for treating wrinkles |
| US5681853A (en) * | 1986-12-23 | 1997-10-28 | Tristrata Technology, Inc. | Methods for improved topical delivery of alpha hydroxyacids |
| US5942250A (en) * | 1986-12-23 | 1999-08-24 | Tristrata Technology, Inc. | Compositions and methods for enhancing the topical effects of sunscreen agents |
| US5889054A (en) * | 1986-12-23 | 1999-03-30 | Tristrata Technology, Inc. | Method of using beta hydroxy acids for treating wrinkles |
| US5684044A (en) * | 1986-12-23 | 1997-11-04 | Tristrata, Incorporated | Methods for improved topical delivery of lactic acid |
| US5690967A (en) * | 1986-12-23 | 1997-11-25 | Tristrata Technology, Inc. | Compositions for improved topical delivery of lactic acid |
| US5691378A (en) * | 1986-12-23 | 1997-11-25 | Tristrata Technology, Inc. | Method for treating wrinkles using combinations of alpha hydroxyacids and/or alpha ketoacids |
| US5702688A (en) * | 1986-12-23 | 1997-12-30 | Tristrata Technology, Inc. | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| US5716992A (en) * | 1986-12-23 | 1998-02-10 | Tristrata Technology, Inc. | Method of using mucic acid or mucolactone for treating wrinkles |
| US5677339A (en) * | 1986-12-23 | 1997-10-14 | Tristrata Technology, Inc. | Method of using mandelic acid for treating wrinkles |
| US5856357A (en) * | 1986-12-23 | 1999-01-05 | Tristrata Technology, Inc. | Method for treating wrinkles using certain alpha hydroxyacids |
| US5834510A (en) * | 1986-12-23 | 1998-11-10 | Tristrata Technology, Inc. | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging |
| US5827882A (en) * | 1986-12-23 | 1998-10-27 | Tristrata Technology, Inc. | Method of using ethyl pyruvate for treating wrinkles |
| JPH05139947A (en) * | 1991-04-10 | 1993-06-08 | Ruey J Yu | Compositions containing 2-hydroxycarboxylic acids and related compounds, and methods for alleviating dermatological signs of aging |
| WO1995015147A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances |
| CN1065527C (en) * | 1994-07-26 | 2001-05-09 | 花王株式会社 | Guanidine derivatives, process for producing granidine derivatives and cosmetics containing guanidine derivatives |
| EP0744175A3 (en) * | 1995-05-23 | 1999-05-19 | Beiersdorf Aktiengesellschaft | Cosmetic or dermatological compositions containing alpha-hydroxy fatty acids |
| FR2737407A1 (en) * | 1995-07-31 | 1997-02-07 | Oreal | USE OF HYDROXYLATED CARBOXYLIC ACIDS FOR THE TREATMENT OF KERATINIC MATERIALS |
| JPH09268120A (en) * | 1996-04-03 | 1997-10-14 | Pola Chem Ind Inc | Water-in-oil type emulsified composition |
| FR2756489A1 (en) * | 1996-12-02 | 1998-06-05 | Eynard Michele | Treatment of hyperkeratoses |
| US6191167B1 (en) | 1997-12-29 | 2001-02-20 | Tristrata Technology, Inc. | Pharmaceutical compositions containing hydroxycarboxylic acid and/or ketocarboxylic acids and methods of using the same |
| JP2000327560A (en) * | 1999-05-18 | 2000-11-28 | Noevir Co Ltd | Bathing agent composition |
| JP2002087923A (en) * | 2000-09-11 | 2002-03-27 | Kose Corp | Cosmetic |
| JP2004244341A (en) * | 2003-02-12 | 2004-09-02 | Noevir Co Ltd | Weakly acidic external preparation for skin and weakly acidic skin cleanser |
| JP2008174525A (en) * | 2007-01-22 | 2008-07-31 | Naris Cosmetics Co Ltd | Toilet lotion |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0330566B2 (en) | 1991-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS588007A (en) | Cosmetic for making skin soft | |
| JP2650883B2 (en) | Use of salicylic acid derivatives as stabilizers for oil-in-water emulsions | |
| US5759557A (en) | Skin care composition | |
| FR2459657A1 (en) | COSMETIC COMPOSITIONS FOR SKIN IN THE FORM OF CREAM OR MILK CONTAINING NATURAL MATERIALS AS EMULSIFIING AGENTS | |
| JPH08283145A (en) | Low-pH external preparation composition for skin | |
| JPH09286715A (en) | Moisturizer and skin external preparation containing the same | |
| JPS6016927A (en) | Agent for promoting sebum secretion | |
| JPS61152613A (en) | Skin cosmetic | |
| US6017548A (en) | Skin care composition | |
| JPH05221821A (en) | Skin-care cosmetic | |
| JPS5826726B2 (en) | Keshiyouriyo | |
| JPH05271046A (en) | Dermal medicine for external use | |
| JPH0314513A (en) | Rinse composition in mouth | |
| JPH0418010A (en) | W/o/w type emulsified cosmetic | |
| JPS62175415A (en) | Skin cosmetic | |
| JPS60116618A (en) | Cosmetic | |
| JP2000198719A (en) | Hair growth agent | |
| JP2780803B2 (en) | External preparation for skin | |
| JP2836772B2 (en) | Cosmetics | |
| JPS60184005A (en) | Cosmetic for preventing aging of skin | |
| JPS6231975B2 (en) | ||
| JPS6281307A (en) | Skin cosmetic | |
| JP2753639B2 (en) | Cosmetics | |
| JPH0233013B2 (en) | SOKONCHIRYOZAI | |
| JPS6127908A (en) | Preventive for chapping |